<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Occasionally an <z:hpo ids='HP_0002617'>aneurysm</z:hpo> is the cause of <z:mp ids='MP_0001914'>hemorrhage</z:mp> in patients with <z:e sem="disease" ids="C0026654" disease_type="Disease or Syndrome" abbrv="MYMY|MYMY1">moyamoya disease</z:e> (MMD) </plain></SENT>
<SENT sid="1" pm="."><plain>We present a case of a ruptured intraventricular distal anterior choroidal artery (AChA) <z:hpo ids='HP_0002617'>aneurysm</z:hpo> treated with n-butyl cyanoacrylic acid (nBCA) (Trufill nBCA Liquid Embolic, Codman Neurovascular, Raynham, Massachusetts, USA) embolization in a patient with MMD </plain></SENT>
<SENT sid="2" pm="."><plain>There were no procedural complications and at 6 month follow-up she remained neurologically <z:mpath ids='MPATH_458'>normal</z:mpath> </plain></SENT>
<SENT sid="3" pm="."><plain>Six month follow-up cerebral angiography showed no residual <z:hpo ids='HP_0002617'>aneurysm</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>The endovascular route is an attractive option for many <z:hpo ids='HP_0002617'>aneurysms</z:hpo> associated with MMD as the lesions can be treated without disturbing the <z:e sem="disease" ids="C0026654" disease_type="Disease or Syndrome" abbrv="MYMY|MYMY1">moyamoya</z:e> collaterals </plain></SENT>
<SENT sid="5" pm="."><plain>nBCA, delivered through a flow-guided microcatheter, is a good embolic agent choice when the lesion is distal on a small vessel and when distal parent <z:mp ids='MP_0006134'>artery occlusion</z:mp> can be tolerated </plain></SENT>
<SENT sid="6" pm="."><plain>Intraventricular AChA <z:hpo ids='HP_0002617'>aneurysms</z:hpo> are well suited for this treatment strategy </plain></SENT>
</text></document>